![Enrique Grande: A Molecular-Directed Strategy with TP53 Mutation in small cell bladder cancer](https://oncodaily.com/pub/uploads/2024/06/IMG_3410.jpeg)
Jun 21, 2024, 05:08
Enrique Grande: A Molecular-Directed Strategy with TP53 Mutation in small cell bladder cancer
Enrique Grande, Head of Oncology at MD Anderson Madrid Cancer Center, recently shared a post on X:
“Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation:
A Molecular-Directed Strategy with TP53 Mutation.”
Additional information.
Source: Enrique Grande/X
Aug 11, 2024, 05:12
Aug 11, 2024, 04:55
Aug 11, 2024, 04:37
Aug 11, 2024, 02:26